New therapies are needed for metastatic breast cancer patients. Oncolytic herpes simplex virus (oHSV) is an exciting therapy being developed for use against aggressive tumors and established metastases. Although oHSV have been demonstrated safe in clinical trials. a lack of sufficient potency has slowed the clinical application of this approach. https://www.markbroyard.com/great-pick-ego-sebitar-solution-500ml-supply-limited-choice/